Cover Image

Functional differences in the mu opioid receptor SNP 118A>G are dependent on receptor splice‐variant and agonist‐specific recruitment of β‐arrestin

Abstract The OPRM1 gene codes for the mu opioid receptor (MOR) and polymorphisms are associated with complex patient clinical responses. The most studied single nucleotide polymorphism (SNP) in OPRM1 is adenine (A) substituted by guanine (G) at position 118 (118A>G, rs1799971) leading to a substi...

Full description

Saved in:

Bibliographic Details
Main Authors:	Casey Patrick (Author), Utibeabasi Ettah (Author), Vu Nguyen (Author), Caitlin Hart (Author), Evan Atchley (Author), Krishna Mallela (Author), Robert I. Scheinman (Author), Andrew A. Monte (Author)
Format:	Book
Published:	Wiley, 2024-08-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Effect of Cell Surface Expression and Linker Sequence on the Recruitment of Arrestin to the GIP Receptor
by: Suleiman Al-Sabah, et al.
Published: (2020)

Analgesic tone conferred by constitutively active mu opioid receptors in mice lacking β-arrestin 2
by: Hales Tim G, et al.
Published: (2011)

A novel alternatively spliced isoform of the mu-opioid receptor: functional antagonism
by: Wentworth Sean, et al.
Published: (2010)

Dopamine-induced arrestin recruitment and desensitization of the dopamine D4 receptor is regulated by G protein-coupled receptor kinase-2
by: Viktor Burström, et al.
Published: (2023)

Investigation of adenosine A1 receptor-mediated β-arrestin 2 recruitment using a split-luciferase assay
by: Luisa Saecker, et al.
Published: (2023)

β‐arrestin2 recruitment at the β2 adrenergic receptor: A luciferase complementation assay adapted for undergraduate training in pharmacology
by: Mattia Ferraiolo, et al.
Published: (2021)

Lack of association between the A118G polymorphism of the mu opioid receptor gene (OPRM1) and opioid  dependence: A meta-analysis
by: Janet K Coller, et al.
Published: (2009)

Identification and characterization of seven new exon 11-associated splice variants of the rat mu opioid receptor gene, OPRM1
by: Pasternak Gavril W, et al.
Published: (2011)

Role of beta-arrestin 2 downstream of dopamine receptors in the basal ganglia
by: Thomas eDel'Guidice, et al.
Published: (2011)

Nitro-benzylideneoxymorphone, a bifunctional mu and delta opioid receptor ligand with high mu opioid receptor efficacy
by: Keith M. Olson, et al.
Published: (2023)

Lack of associations of the opioid receptor mu 1 (OPRM1) A118G polymorphism (rs1799971) with alcohol dependence: review and meta-analysis of retrospective controlled studies
by: Xiangyi Kong, et al.
Published: (2017)

Mu-opioid receptor expression in multibacillary leprosy
by: Patrícia Elizabeth Pignataro, et al.
Published: (2019)

Splice variants of androgen receptor and prostate cancer
by: Orazio Caffo, et al.
Published: (2016)

G Protein-Coupled Receptor Kinases (GRKs) and Beta-Arrestins: New Insights into Disease Regulators
Published: (2020)

Exploration of beta-arrestin isoform signaling pathways in delta opioid receptor agonist-induced convulsions
by: Arryn T. Blaine, et al.
Published: (2022)

Functional selectivity of EM-2 analogs at the mu-opioid receptor
by: Justyna Piekielna-Ciesielska, et al.
Published: (2023)

Heteromerization Modulates mu Opioid Receptor Functional Properties in vivo
by: Muzeyyen Ugur, et al.
Published: (2018)

Editorial: G Protein-Coupled Receptor Kinases (GRKs) and β-Arrestins: New Insights Into Disease Regulators
by: Yuichi Hattori, et al.
Published: (2020)

Cannabinoid CB1 and CB2 Receptor-Mediated Arrestin Translocation: Species, Subtype, and Agonist-Dependence
by: Mikkel Søes Ibsen, et al.
Published: (2019)

β-Arrestin Based Receptor Signaling Paradigms: Potential Therapeutic Targets for Complex Age-Related Disorders
by: Jaana van Gastel, et al.
Published: (2018)

Dual-Color Bioluminescence Analysis for Quantitatively Monitoring G-Protein-Coupled Receptor and β-Arrestin Interactions
by: Naomi Misawa, et al.
Published: (2011)

ClickArr: a novel, high-throughput assay for evaluating β-arrestin isoform recruitment
by: Alexander R. French, et al.
Published: (2023)

It's MORe exciting than mu: Crosstalk between mu opioid receptors and glutamatergic transmission in the mesolimbic dopamine system
by: Elena H Chartoff, et al.
Published: (2014)

β-arrestin biased signaling is not involved in the hypotensive actions of 5-HT7 receptor stimulation: use of Serodolin
by: Stephanie W. Watts, et al.
Published: (2024)

Monoclonal antibody targeting mu-opioid receptor attenuates morphine tolerance via enhancing morphine-induced receptor endocytosis
by: Jia-Jia Zhang, et al.
Published: (2023)

Comparative analyses of downstream signal transduction targets modulated after activation of the AT1 receptor by two β-arrestin biased agonists
by: Geisa A Santos, et al.
Published: (2015)

Modulation of Morphine Analgesia, Antinociceptive Tolerance, and Mu-Opioid Receptor Binding by the Cannabinoid CB2 Receptor Agonist O-1966
by: Zachary W. Reichenbach, et al.
Published: (2022)

Long‐term antagonism and allosteric regulation of mu opioid receptors by the novel ligand, methocinnamox
by: Joshua C. Zamora, et al.
Published: (2021)

HBK-17, a 5-HT1A Receptor Ligand With Anxiolytic-Like Activity, Preferentially Activates ß-Arrestin Signaling
by: Karolina Pytka, et al.
Published: (2018)

Tyrosine 7.43 is important for mu-opioid receptor downstream signaling pathways activated by fentanyl
by: Xiangyun Tian, et al.
Published: (2022)

Mu Opioid Receptor Heterodimers Emerge as Novel Therapeutic Targets: Recent Progress and Future Perspective
by: Li Zhang, et al.
Published: (2020)

Follicle-stimulating hormone (FSH) activates extracellular signal-regulated kinase phosphorylation independently of beta-arrestin- and dynamin-mediated FSH receptor internalization
by: Crepieux Pascale, et al.
Published: (2006)

Therapeutic Potential of Targeting ß-Arrestin
by: Richard A. Bond, et al.
Published: (2019)

Possible biased analgesic of hydromorphone through the G protein-over β-arrestin-mediated pathway: cAMP, CellKey™, and receptor internalization analyses
by: Sei Manabe, et al.
Published: (2019)

Bispecific sigma-1 receptor antagonism and mu-opioid receptor partial agonism: WLB-73502, an analgesic with improved efficacy and safety profile compared to strong opioids
by: Alba Vidal-Torres, et al.
Published: (2023)

Leptin receptor (LEPR) SNP polymorphisms in HELLP syndrome patients determined by quantitative real-time PCR and melting curve analysis
by: Than Nándor, et al.
Published: (2010)

GPCR Signaling Regulation: The Role of GRKs and Arrestins
by: Vsevolod V. Gurevich, et al.
Published: (2019)

Structural features of arrestin-mediated GPCR signaling
by: Wenqin Xie, et al.
Published: (2024)

Continuous Activation of Dopamine Receptors Alleviates LPS-Induced Liver Injury in Mice via β-arrestin2 Dependent Akt/NF-κB Pathway
by: Mingan Li, et al.
Published: (2022)

The Use of Peripheral μ-Opioid Receptor Antagonists (PAMORA) in the Management of Opioid-Induced Constipation: An Update on Their Efficacy and Safety
by: Pergolizzi JV Jr, et al.
Published: (2020)